Cite
APA Citation
Nishio, M., Seto, T., Reck, M., Garon, E. B., Chiu, C., Yoh, K., Imamura, F., Park, K., Shih, J., Visseren‐Grul, C., Frimodt‐Moller, B., Zimmermann, A., Homma, G., Enatsu, S., Nakagawa, K., & , (2020). ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY. Cancer science, 111(12), 4510–4525. http://access.bl.uk/ark:/81055/vdc_100118097139.0x00000f